Antitumor activity against P338 leukemia cells measured as T/C(average survival time of treated mice/control mice*100)at 0.4 mg/kg, ip optimal dose on day 1 in mice
Antitumor activity against P338 leukemia cells measured as T/C(average survival time of treated mice/control mice*100)at 0.4 mg/kg, ip optimal dose on days 1-5 in mice
Antitumor activity against P338 leukemia cells measured as T/C(average survival time of treated mice/control mice*100)at 1.56 mg/kg, ip optimal dose on days 1-5 in mice
Antitumor activity against P338 leukemia cells measured as T/C(average survival time of treated mice/control mice*100)at 12.5 mg/kg, ip optimal dose on days 1-5 in mice
Antitumor activity against P338 leukemia cells measured as T/C(average survival time of treated mice/control mice*100)at 25 mg/kg, ip optimal dose on day 1 in mice
Antitumor activity against P338 leukemia cells measured as T/C(average survival time of treated mice/control mice*100)at 25 mg/kg, ip optimal dose on days 1-5 in mice
Antitumor activity against P338 leukemia cells measured as T/C(average survival time of treated mice/control mice*100)at 3.12 mg/kg, ip optimal dose on days 1-5 in mice
Antitumor activity against P338 leukemia cells measured as T/C(average survival time of treated mice/control mice*100)at 6.25 mg/kg, ip optimal dose on day 1 in mice
Antitumor activity against P338 leukemia cells measured as T/C(average survival time of treated mice/control mice*100)at 6.25 mg/kg, ip optimal dose on days 1-5 in mice